Page last updated: 2024-11-03

ono 1078 and Bronchial Diseases

ono 1078 has been researched along with Bronchial Diseases in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Bronchial Diseases: Diseases involving the BRONCHI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamilton, A1
Faiferman, I1
Stober, P1
Watson, RM1
O'Byrne, PM1

Trials

1 trial available for ono 1078 and Bronchial Diseases

ArticleYear
Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.
    The Journal of allergy and clinical immunology, 1998, Volume: 102, Issue:2

    Topics: Adolescent; Adult; Allergens; Anti-Asthmatic Agents; Asthma; Bronchial Diseases; Chromones; Cross-Ov

1998